Patent Yard Sign in
Canadian application, no grantCanada

Indolylpiperidine derivatives as antihistaminic and antiallergic agents

CA 2375985 A1 · Owner: Puig Duran, Carles · Inventors: Puig Duran, Carles; Fernandez Forner, Dolors; Pages Santacana, Lluis

CIPO record

Overview

Drawings and full text

Its claims, description and drawings are in the Canadian Patents Database.

Open the CIPO record

Abstract From the Canadian patent

Indolylpiperidine compounds of formula (I) wherein: A1 represents an alkylene alkyleneoxy, alkylenethio, alkanoyl or hydroxyalkylene group; A2 represents a single bond, an alkylene or alkenylene group; W represents a single bond or a phenylene or furanylene group which is unsubstituted or substituted by one or more halogen atoms, alkoxy groups and/or alkyl groups; R2 represents a hydrogen or halogen atom or an alkyl or alkoxy group; and R3 represents a carboxyl group or a tetrazolyl group. The present invention provides novel indolylpiperidine compounds having improved antihistamine and antiallergic activity.

Read the whole patent

Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.

Why it's free to use

  • Filed May 31, 2000. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended May 31, 2020.
  • A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by May 31, 2022.
  • We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
FiledMay 31, 2000
GrantedNo grant recorded
Term endedMay 31, 2020
Patent numberCA 2375985 A1
Classification (IPC)C07D401/04 +2 more

Timeline

Timeline From CIPO dates

2001200320052007200920112013201520172019Application filedMay 31, 2000Term endedMay 31, 2020

Sources & verification

Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.